Ionis Subsidiary Akcea Files $100M IPO Led By Cooley
Akcea Therapeutics Inc., a late-stage biotech being spun out of Ionis Pharmaceuticals Inc., on Monday filed a $100 million initial public offering under guidance from Cooley LLP, seeking to raise money...To view the full article, register now.
Already a subscriber? Click here to view full article